Point72 Hong Kong LTD Forma Therapeutics Holdings, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $3,141 - $6,160	616 New	616 $4,000
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $12,756 - $23,346	-938 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $19,904 - $24,106	938 New	938 $22,000
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $172,262 - $262,707	-5,228 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $203,892 - $243,049	5,228 New	5,228 $243,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.